Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-065275
Filing Date
2015-09-15
Accepted
2015-09-15 16:31:22
Documents
1
Period of Report
2015-09-11

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4010
  Complete submission text file 0001104659-15-065275.txt   5411
Mailing Address 3200 WALNUT ST BOULDER CO 80301
Business Address
MOORE JOHN R (Reporting) CIK: 0001191702 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 151108033

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations